ShopKo Reports February Retail Sales

ShopKo Reports February Retail Sales

(Year End Conference Call Arrangements Provided)

GREEN BAY, Wis., March 3 /PRNewswire-FirstCall/ -- ShopKo Stores, Inc. (NYSE:SKO), today reported consolidated sales for the four weeks ended February 26, 2005 decreased 3.0 percent to $212.9 million from $219.5 million during the same period last year. Consolidated comparable store sales decreased 3.4 percent.

Sales Summary by Business Segment (dollars in millions)

Retail Segments Period Ended % Change
4 Weeks: 2/26/05 Total** Comp*

ShopKo $157.8 (5.4)% (5.6)%
Pamida 55.1 4.5 3.4
Total Retail $212.9 (3.0)% (3.4)%

* Comparable store sales represent sales of those stores open during both
fiscal years and do not include sales from the ShopKo wholesale optical
lab.
** ShopKo division total sales variance reflects sales from one closed
ShopKo location in fiscal 2004 and three new ShopKo Express Rx
locations. Pamida division total sales variance reflects sales from
five closed Pamida locations and seven new locations in fiscal 2004.

Although sales at the ShopKo division were below expectations, the division continues to focus on gross margin performance.

For the month of March 2005, the company expects to be positively impacted by the Easter holiday shift and expects consolidated comparable store sales to be in the positive low single digit range.

Fourth Quarter/Year End Conference Call Arrangements

ShopKo Stores, Inc. will host a conference call and real-time webcast March 10, 2005, at 10:30 a.m. Central Standard Time (CST) to discuss fourth quarter and year end results and fiscal 2005 outlook. Participants may access the conference by dialing (800) 860-2442 and asking for the ShopKo Stores, Inc. conference call. The webcast will be archived for two weeks at http://www.shopko.com/ .

The call will be rebroadcast immediately following the call through March 18, 2005. The replay can be accessed by dialing (877) 344-7529 or (412) 317-0088. When prompted for an account number dial 718#, then dial 1 for the recorded conference. When prompted for the conference number dial 364641#, then press 1 to begin the playback.

ShopKo Stores, Inc. provides weekly updates on consolidated comparable store sales. A real time audio recording of the previous week's results will be available after 10:00 a.m. CST Monday by calling (920) 429-4646. These recorded messages will not be available on the Monday preceding monthly sales releases.

ShopKo Stores, Inc. is a retailer of quality goods and services headquartered in Green Bay, Wis., with stores located throughout the Midwest, Mountain and Pacific Northwest regions. Retail formats include 140 ShopKo stores, providing quality name-brand merchandise, great values, pharmacy and optical services in mid-sized to larger cities; 220 Pamida stores, 113 of which contain pharmacies, bringing value and convenience close to home in small, rural communities; and three ShopKo Express Rx stores, a new and convenient neighborhood drugstore concept. With more than $3.0 billion in annual sales, ShopKo Stores, Inc. is listed on the New York Stock Exchange under the symbol SKO. For more information about ShopKo, Pamida or ShopKo Express Rx, visit our Web site at http://www.shopko.com/ .

This press release contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, including statements regarding expected sales and other financial results. Such statements are subject to important factors that could cause ShopKo's actual results to differ materially from those anticipated by the forward-looking statements including those referenced in ShopKo's current annual report on Form 10-K or as may be described from time to time in ShopKo's subsequent SEC filings; and such factors are incorporated by reference.

Source: ShopKo Stores, Inc.

CONTACT: Media, John Vigeland, +1-920-429-4132, or Investors, Jenine
Maloney, +1-920-429-7039, both of ShopKo Stores, Inc.

Web site: http://www.shopko.com/

-------
Profile: intent